Pharmerging Versus Mature Pharmaceutical Markets: Where is Pharma Going? Where is Pharma Growing?
Pharmerging Versus Mature Pharmaceutical Markets: Where is Pharma Going? Where is Pharma Growing?
Attachment: IIR Table - Pharmaceutical Industry Ranked by Country
SUGAR LAND--August 12, 2009--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--One of the latest trendy phrases zipping around the Pharmaceutical Industry is "pharmerging markets." The phrase was coined to refer to the emerging world markets that are expected to experience double-digit growth, which, in turn, will unfortunately be offset by the lackluster performance predicted in established markets. The pharmerging areas are poised to receive the next major influx of capital activity from all of the Pharmaceutical Industry majors, e.g. Pfizer Incorporated (NYSE:PFE), GlaxoSmithKline plc (NYSE:GSK), Merck & Company Incorporated (NYSE:MRK), albeit with a definite risk of losing both intellectual and physical property.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects